K2M’s IPO Could Reap As Much As $183 Million

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

K2M says its forthcoming initial public offering could garner as much as $183 million, if its underwriters exercise a 1.3 million-share over-allotment. K2M Group Holdings, the largest privately held spinal implant maker, said today that its forthcoming initial public offering could be worth up to $183 million. K2M announced its plans for a U.S. IPO early this year, saying in March that the launch could be worth $100 million.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC